Fundraising FoxNext Cell Pharma AB
1 known investors
Find your way into Next Cell Pharma AB
Sign up to see every warm intro you have to Next Cell Pharma AB
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Next Cell Pharma AB team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NextCell Pharma is a Swedish biotech company developing stem cell therapies (advanced therapy medicinal products) focused primarily on autoimmune and inflammatory diseases, with its lead candidate ProTrans targeting type 1 diabetes. The company operates three business areas — Cellaviva, ProTrans, and QVance — and runs Cellaviva, described as Scandinavia's largest stem cell bank.
Investors · 1
Frequently asked questions
- What does Next Cell Pharma AB do?
- NextCell Pharma is a Swedish biotech company developing stem cell therapies (advanced therapy medicinal products) focused primarily on autoimmune and inflammatory diseases, with its lead candidate ProTrans targeting type 1 diabetes. The company operates three business areas — Cellaviva, ProTrans, and QVance — and runs Cellaviva, described as Scandinavia's largest stem cell bank.
- Who are Next Cell Pharma AB's investors?
- Next Cell Pharma AB's investors include 1921 Ventures.